The Society for Immunotherapy of Cancer (SITC) is a global non‑profit medical professional society dedicated to advancing the science, development, and clinical application of cancer immunotherapy. It brings together researchers, clinicians, industry leaders, and other stakeholders to share knowledge through scientific meetings, educational programmes, and collaborative initiatives aimed at improving outcomes for patients.
SITC also supports guidelines, publications, and community activities designed to accelerate research translation and broaden understanding of immunotherapy approaches.
